Variables | RFS | Â | OS | Â |
---|---|---|---|---|
 | HR (95% CI) | P-value | HR (95% CI) | P-value |
Sex | ||||
 Female | 1 |  | 1 |  |
 Male | 1.181 (0.898–1.554) | 0.233 | 0.963 (0.753–1.231) | 0.763 |
Age | ||||
 < 50 year-old | 1 |  | 1 |  |
 50–65 year-old | 1.434 (0.925–2.223) | 0.107 | 1.144 (0.749–1.745) | 0.534 |
 65–80 year-old | 1.114 (0.718–1.729) | 0.630 | 1.361 (0.910–2.034) | 0.134 |
 ≥80 year-old | 1.249 (0.704–2.216) | 0.446 | 2.951 (1.856–4.692) | < 0.001 |
CEA, pre-operation | ||||
 ≥5 ng/mL | 1 |  | 1 |  |
 < 5 ng/mL | 0.611 (0.463–0.806) | < 0.001 | 0.717 (0.560–0.918) | 0.008 |
NLR, pre-operation | ||||
 ≥ 2.87 | 1 |  | 1 |  |
 <  2.87 | 1.054 (0.796–1.397) | 0.713 | 0.864 (0.664–1.124) | 0.277 |
Histology type | ||||
 Adenocarcinoma | 1 |  | 1 |  |
 Signet ring cell | 1.509 (0.528–4.313) | 0.443 | 2.691 (1.128–6.418) | 0.026 |
 Mucinous | 0.927 (0.582–1.477) | 0.751 | 1.038(0.693–1.554) | 0.856 |
Histology grade | ||||
 Poorly | 1 |  | 1 |  |
 Moderate | 1.231 (0.823–1.842) | 0.311 | 1.262 (0.884–1.802) | 0.200 |
 Well | 0.792 (0.396–1.583) | 0.509 | 0.719 (0.381–1.356) | 0.308 |
NLN | ||||
 <  27 | 1 |  | 1 |  |
 ≥ 27 | 0.613 (0.463–0.812) | 0.001 | 0.626 (0.487–0.804) | < 0.001 |
Stage III | ||||
 IIIA | 1 |  | 1 |  |
 IIIB | 8.661 (1.207–62.167) | 0.032 | 1.990 (0.809–4.894) | 0.134 |
 IIIC | 19.874 (2.746–143.811) | 0.003 | 4.030 (1.612–10.076) | 0.003 |
Adjuvant C/T | ||||
 No | 1 |  | 1 |  |
 Yes | 0.702 (0.484–1.018) | 0.062 | 0.517 (0.387–0.690) | <  0.001 |